Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

Quanterix

Biotech & Life Sciences · Lexington, United States · Founded 2007 · IPO 2017 Unicorn

A company that is digitizing biomarker analysis with the goal of advancing the science of precision health

Valuation
$66M
Market cap · May/2026
Revenue
$139M
Latest reported FY

Investors

9 investors on Quanterix's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 6 investors entered at this stage

Global footprint

Where Quanterix has talent and traffic

AI talent share
0.2% of workforce is AI talent
(1 of 508 staff)
Core AI00%
Other AI10.2%
Non-AI workforce50799.8%
Workforce by country
15 countries with
team presence
🇺🇸 United States90%
🇨🇳 China2.3%
🇬🇧 United Kingdom1.6%
🇮🇹 Italy1.2%
🇪🇸 Spain0.9%
Top 5 of 15 shown
Web traffic by country
49K monthly visits
across markets
🇺🇸 United States31.2%
🇬🇧 United Kingdom8.2%
🏳️ Korea7.6%
🏳️ Republic of4.9%
🇨🇦 Canada4.7%
Top 5 markets shown

Patent intelligence

$18M patent portfolio · 13 active families

Estimated portfolio value
$18M
27.3% of market cap · 27.8× smaller than top peer Insulet ($502M)
13 active patent families
Where Quanterix innovates Analyte moleculeAssayUltra sensitiveMolecular biologyBioinformatics

Where Quanterix concentrates vs peers

Each axis is a top-10 topic across Quanterix and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Capital deployed

Quanterix's 3 investments and acquisitions.

Every disclosed deal where Quanterix appeared as a backer or acquirer, 2019–2025. Toggle between venture rounds, M&A, or both. The map below is grouped by the target company's sector — the colored pill on each chip is the round type.

Portfolio analysis

3 deals across Quanterix's capital deployment.

Where the deals concentrate by sector, stage, and decade.

By sectorCount
    By stageCount
      By periodCount

        01 · Deployment strategy vs peers

        Where Quanterix deploys vs peers

        Each axis is a Dealroom topic tag — picked from the cluster's most-tagged themes. Values are normalized per axis: the peer with the highest tag-coverage on that axis sits at the edge, others scale relative to them. Toggle between M&A, venture, or both.

        Compare against

        02 · Portfolio market map

        Quanterix's portfolio, mapped.

        Each chip is one company. Pill colour shows round type — green for Seed, blue for Series A, purple for B/C+, pink for late-stage, amber for M&A. Bigger sectors keep their full list behind “+ N more”.

        Stage
        Period
        3 of 3 deals

        Market sentiment

        What the market is saying about Quanterix

        An AI-synthesized read of the highest-engagement posts about Quanterix on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

        Reading the room on X — pulling top posts and synthesizing themes…

        Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

        See Quanterix on the full Dealroom platform

        Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.